OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Clinical Dermatology is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)

Article	Citations
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative	161
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions	155
Prognostic Biomarkers in Evolving Melanoma Immunotherapy	143
The Current State of Systemic Therapy of Metastatic Uveal Melanoma	131
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review	100
Economic Burden of Chronic Hand Eczema: A Review	99
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments	96
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments	86
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know	86
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study	80
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology	75
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review	72
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?	71
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data	70
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution	66
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroi	56
Pathophysiology of Generalized Pustular Psoriasis	54
Primary Localized Cutaneous Amyloidosis of Keratinocyte Origin: An Update with Emphasis on Atypical Clinical Variants	53
A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris	52
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	51
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment	49
Inpatient Teledermatology Improves Diagnostic Accuracy and Management of Leg Ulcers in Hospitalized Patients	48
Disease Modification in Psoriasis: Future Prospects for Long-Term Remission	48
Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”	47
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation	45

Lessons Learned from Orthopedics: A Call to Action for More Rigorous Platelet-Rich Plasma Hair Loss Clinical Trials	45
Skin Cancer in People of Color: A Systematic Review	45
Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature	44
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study	44
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives	43
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment	41
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis	40
A Practice Approach to Acne Fulminans in Adolescents	39
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis	39
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management	39
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment Hist	38
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	37